Pharmacological inhibition of prolyl hydroxylase protects against inflammation-induced anemia via efficient erythropoiesis and hepcidin downregulation. [electronic resource]
Producer: 20190415Description: 113-120 p. digitalISSN:- 1879-0712
- Anemia -- drug therapy
- Animals
- Down-Regulation
- Erythropoiesis -- drug effects
- Erythropoietin -- blood
- Female
- Hepcidins -- blood
- Inflammation -- complications
- Iron -- metabolism
- Liver -- drug effects
- Male
- Mice, Inbred BALB C
- Prolyl-Hydroxylase Inhibitors -- pharmacology
- Quinolones -- pharmacology
- Rats, Inbred Lew
- Reticulocyte Count
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.